Scanfil Oyj
24.2.2021 06:25:06 CET | Globenewswire | Press release
SCANFIL PLC MANAGERS' TRANSACTIONS 23 February 2021 3:30 P.M.
Scanfil Plc - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Kosunen, Markku
Position: Other senior manager
Issuer: Scanfil Oyj
LEI: 7437004XD6U0FFDCT507
Notification type: INITIAL NOTIFICATION
Reference number: 7437004XD6U0FFDCT507_20210223093356_2
____________________________________________
Transaction date: 2021-02-18
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000029905
Nature of the transaction: DISPOSAL
Transaction details
(1): Volume: 36 Unit price: 7.08 EUR
(2): Volume: 900 Unit price: 7.02 EUR
(3): Volume: 40 Unit price: 7.02 EUR
(4): Volume: 2,466 Unit price: 7 EUR
(5): Volume: 41 Unit price: 7 EUR
(6): Volume: 492 Unit price: 7 EUR
(7): Volume: 250 Unit price: 7 EUR
(8): Volume: 41 Unit price: 7 EUR
(9): Volume: 37 Unit price: 7 EUR
(10): Volume: 100 Unit price: 7 EUR
Aggregated transactions
(10): Volume: 4,403 Volume weighted average price: 7.00492 EUR
____________________________________________
Transaction date: 2021-02-19
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000029905
Nature of the transaction: DISPOSAL
Transaction details
(1): Volume: 154 Unit price: 7.02 EUR
(2): Volume: 235 Unit price: 7.02 EUR
(3): Volume: 1,601 Unit price: 7.02 EUR
Aggregated transactions
(3): Volume: 1,990 Volume weighted average price: 7.02 EUR
SCANFIL PLC
Petteri Jokitalo
CEO
For additional information:
CEO Petteri Jokitalo
tel. +358 8 4882 111
www.scanfil.com
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S25.10.2026 12:00:00 CET | Press release
Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
